” Allogenica is a young company developing universal cell therapies to treat certain forms of cancer. Benkei worked with us as part of the i-Lab national innovation competition. Relying on the knowledge acquired about our company during this process, Benkei was able to provide us with an effective guidance in setting up our JEI rescript, thereby securing the French tax exemptions from employer contributions that are vital to a start-up’s economic balance. “
Laure Vidalain, Chief Operating Officer